MGX · Forms 3, 4, 5
Insider trades at Metagenomi Therapeutics, Inc.
3 insiders sold $5K and 1 insider bought $23K of Metagenomi Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Metagenomi Therapeutics, Inc. (MGX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Laurence Reid | Director | Buy | 19,883 | $1.17 | $23K | Form 4 | |
| Laurence Reid | Director | Buy | 117 | $1.18 | $138 | Form 4 | |
| Matthew Wein | General Counsel, Compliance Officer and Corporate Secretary | Sell | 358 | $1.16 | $415 | Form 4 | |
| Jian Irish | Director | Sell | 2,140 | $1.16 | $2K | Form 4 | |
| Pamela Wapnick | Chief Financial Officer | Sell | 1,911 | $1.16 | $2K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.